{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:10:06Z","timestamp":1751602206468,"version":"3.41.0"},"reference-count":114,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128122181"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-12-812218-1.00006-3","type":"book-chapter","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T18:39:07Z","timestamp":1525372747000},"page":"147-168","source":"Crossref","is-referenced-by-count":0,"title":["Targeting of Lipid\/Polymeric (Hybrid) Nanoparticles to the Brain for the Treatment of Degenerative Diseases"],"prefix":"10.1016","author":[{"given":"M.C.","family":"Teixeira","sequence":"first","affiliation":[]},{"given":"C.","family":"Martins-Gomes","sequence":"additional","affiliation":[]},{"given":"K.K.","family":"Singh","sequence":"additional","affiliation":[]},{"given":"F.J.","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"A.M.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"E.B.","family":"Souto","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"issue":"6116","key":"10.1016\/B978-0-12-812218-1.00006-3_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.1227901","article-title":"Microglia: Scapegoat, Saboteur, or Something Else?","volume":"339","author":"Aguzzi","year":"2013","journal-title":"Science"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib3","first-page":"795","article-title":"Nanoscale drug delivery systems and the blood-brain barrier","volume":"9","author":"Alyautdin","year":"2014","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biomaterials.2015.12.008","article-title":"Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: Application to Huntington\u2019s disease","volume":"83","author":"Andr\u00e9","year":"2016","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/B978-0-12-812218-1.00006-3_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1212\/WNL.0b013e318263c443","article-title":"Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"79","author":"Armstrong","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"Alzheimer\u2019s Association Report 2015 Alzheimer\u2019s disease facts and figures","volume":"11","author":"Assoc","year":"2015","journal-title":"Alzheimers & Dementia"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib8","first-page":"535","article-title":"Natural compounds and neuroprotection: Mechanisms of action and novel delivery systems","volume":"30","author":"Bagli","year":"2016","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: The problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib10","first-page":"65","article-title":"Parkinson\u2019s disease: A review","volume":"6","author":"Beitz","year":"2014"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib11","first-page":"600","article-title":"Physiology and pharmacological role of the blood-brain barrier","volume":"60","author":"Bernacki","year":"2008","journal-title":"Pharmacological Reports"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib12","article-title":"Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes","volume":"9","author":"Boyer-Di Ponio","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nano.2011.03.008","article-title":"Nanotechnologies for Alzheimer\u2019s disease: Diagnosis, therapy, and safety issues","volume":"7","author":"Brambilla","year":"2011","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib14","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1021\/nn5018523","article-title":"Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier","volume":"8","author":"Bramini","year":"2014","journal-title":"Acs Nano"},{"issue":"7","key":"10.1016\/B978-0-12-812218-1.00006-3_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","article-title":"Highly stabilized curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in Alzheimer\u2019s disease Tg2576 mice","volume":"15","author":"Cheng","year":"2013","journal-title":"The AAPS Journal"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5483\/BMBRep.2008.41.5.345","article-title":"Blood-neural barrier: Its diversity and coordinated cell-to-cell communication","volume":"41","author":"Choi","year":"2008","journal-title":"Bmb Reports"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.msec.2016.11.060","article-title":"L-dopa co-drugs in nanostructured lipid carriers: A comparative study","volume":"72","author":"Cortesi","year":"2017","journal-title":"Materials Science and Engineering: C"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1755-5949.2010.00199.x","article-title":"Nanoparticulate systems for drug delivery and targeting to the central nervous system","volume":"17","author":"Craparo","year":"2011","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/106002809402800612","article-title":"Tacrine: First drug approved for Alzheimer\u2019s disease","volume":"28","author":"Crismon","year":"1994","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.05.002","article-title":"Engineered nanoparticles. How brain friendly is this new guest?","volume":"119","author":"Cupaioli","year":"2014","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","article-title":"Huntington disease: Pathogenesis and treatment","volume":"33","author":"Dayalu","year":"2015","journal-title":"Neurologic Clinics"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","article-title":"Size and shape effects in the biodistribution of intravascularly injected particles","volume":"141","author":"Decuzzi","year":"2010","journal-title":"Journal of Controlled Release"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/156802609787521571","article-title":"Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain","volume":"9","author":"Denora","year":"2009","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.2042-7158.2010.01225.x","article-title":"Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery","volume":"63","author":"Dhawan","year":"2011","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-812218-1.00006-3_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2016.02.039","article-title":"Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies","volume":"502","author":"Fangueiro","year":"2016","journal-title":"International Journal of Pharmaceutics"},{"issue":"13","key":"10.1016\/B978-0-12-812218-1.00006-3_bib28","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1073\/pnas.88.13.5779","article-title":"Blood-brain-barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes - an electron-microscopic immunogold study","volume":"88","author":"Farrell","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"17","key":"10.1016\/B978-0-12-812218-1.00006-3_bib29","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.4155\/fmc-2016-0135","article-title":"Liposomal drug delivery systems for targeted cancer therapy: Is active targeting the best choice?","volume":"8","author":"Fathi","year":"2016","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib30","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1016\/B978-0-12-812218-1.00006-3_bib32","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1021\/nn5003375","article-title":"Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist","volume":"8","author":"Gao","year":"2014","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/B978-0-12-812218-1.00006-3_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0166-2236(00)01617-9","article-title":"Serine proteases and brain damage \u2013 is there a link?","volume":"23","author":"Gingrich","year":"2000","journal-title":"Trends in Neurosciences"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib34","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/nn501292z","article-title":"Precision nanomedicine in neurodegenerative diseases","volume":"8","author":"Goldsmith","year":"2014","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/B978-0-12-812218-1.00006-3_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081043","article-title":"Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro","volume":"8","author":"Gromnicova","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2217\/nnm.10.74","article-title":"Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide","volume":"5","author":"Guerrero","year":"2010","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/B978-0-12-812218-1.00006-3_bib37","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","article-title":"Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain","volume":"59","author":"Gupta","year":"2007","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib38","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/ijms15021812","article-title":"Cell-based in vitro blood-brain barrier model can rapidly evaluate nanoparticles\u2019 brain permeability in association with particle size and surface modification","volume":"15","author":"Hanada","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood-brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1016\/B978-0-12-812218-1.00006-3_bib40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12640-016-9663-z","article-title":"Nanomedicine to overcome current Parkinson\u2019s treatment liabilities: A systematic review","volume":"30","author":"Hawthorne","year":"2016","journal-title":"Neurotoxicity Research"},{"issue":"12","key":"10.1016\/B978-0-12-812218-1.00006-3_bib41","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1021\/nn403743b","article-title":"Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain","volume":"7","author":"Heckman","year":"2013","journal-title":"ACS Nano"},{"issue":"49","key":"10.1016\/B978-0-12-812218-1.00006-3_bib42","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/21\/49\/499802","article-title":"Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: Apomorphine as a model drug (vol 21, 405101, 2010)","volume":"21","author":"Hsu","year":"2010","journal-title":"Nanotechnology"},{"issue":"7","key":"10.1016\/B978-0-12-812218-1.00006-3_bib43","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1021\/nn200365a","article-title":"The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo","volume":"5","author":"Huang","year":"2011","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib44","doi-asserted-by":"crossref","first-page":"H1241","DOI":"10.1152\/ajpheart.2001.280.3.H1241","article-title":"Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression","volume":"280","author":"Huber","year":"2001","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037376","article-title":"Conjugation of functionalized SPIONs with transferrin for targeting and imaging brain glial tumors in rat model","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/B978-0-12-812218-1.00006-3_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/17425255.2016.1158250","article-title":"Advances in understanding genomic markers and pharmacogenetics of Parkinson\u2019s disease","volume":"12","author":"Jimenez-Jimenez","year":"2016","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"12","key":"10.1016\/B978-0-12-812218-1.00006-3_bib47","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/bc200406n","article-title":"In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles","volume":"22","author":"Jin","year":"2011","journal-title":"Bioconjugate Chemistry"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0169-409X(02)00176-X","article-title":"Pluronic((R)) block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier","volume":"55","author":"Kabanov","year":"2003","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"11","key":"10.1016\/B978-0-12-812218-1.00006-3_bib49","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1016\/j.fct.2011.08.006","article-title":"Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain","volume":"49","author":"Kakkar","year":"2011","journal-title":"Food and Chemical Toxicology"},{"issue":"44","key":"10.1016\/B978-0-12-812218-1.00006-3_bib50","doi-asserted-by":"crossref","first-page":"13761","DOI":"10.1523\/JNEUROSCI.4246-09.2009","article-title":"A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection","volume":"29","author":"Karatas","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib51","first-page":"20","article-title":"Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis","volume":"213","author":"Kizelsztein","year":"2009","journal-title":"Journal of Neurochemistry"},{"issue":"46","key":"10.1016\/B978-0-12-812218-1.00006-3_bib52","doi-asserted-by":"crossref","first-page":"18837","DOI":"10.1073\/pnas.1111405108","article-title":"Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging","volume":"108","author":"Koffie","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"26","key":"10.1016\/B978-0-12-812218-1.00006-3_bib53","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1073\/pnas.1308345110","article-title":"Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium","volume":"110","author":"Kolhar","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2012.09.021","article-title":"Magnetic targeting of nanoparticles across the intact blood-brain barrier","volume":"164","author":"Kong","year":"2012","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.addr.2012.09.015","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"64","author":"Kreuter","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids and Surfaces B-Biointerfaces"},{"issue":"10","key":"10.1016\/B978-0-12-812218-1.00006-3_bib57","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425240903167942","article-title":"New strategies to deliver anticancer drugs to brain tumors","volume":"6","author":"Laquintana","year":"2009","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"49","key":"10.1016\/B978-0-12-812218-1.00006-3_bib58","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/49\/495101","article-title":"Shaping nano-\/micro-particles for enhanced vascular interaction in laminar flows","volume":"20","author":"Lee","year":"2009","journal-title":"Nanotechnology"},{"issue":"12","key":"10.1016\/B978-0-12-812218-1.00006-3_bib59","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.1303258","article-title":"Activation of the STING adaptor attenuates experimental autoimmune encephalitis","volume":"192","author":"Lemos","year":"2014","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1016\/B978-0-12-812218-1.00006-3_bib60","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bbamem.2009.06.022","article-title":"Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer","volume":"1788","author":"Li","year":"2009","journal-title":"Biochimica Et Biophysica Acta-Biomembranes"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.expneurol.2008.02.005","article-title":"Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: Long-term protective effects and enhanced efficacy of methylprednisolone formulations","volume":"211","author":"Linker","year":"2008","journal-title":"Experimental Neurology"},{"issue":"11","key":"10.1016\/B978-0-12-812218-1.00006-3_bib62","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1242\/jcs.113.11.2011","article-title":"The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)","volume":"113","author":"Litman","year":"2000","journal-title":"Journal of Cell Science"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10571-015-0178-6","article-title":"PEG-PEI\/siROCK2 protects against a beta42-induced neurotoxicity in primary neuron cells for Alzheimer disease","volume":"35","author":"Liu","year":"2015","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000255578","article-title":"Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer\u2019s disease: Systematic review of the \u2018real-world\u2019 evidence","volume":"28","author":"Lockhart","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"9-10","key":"10.1016\/B978-0-12-812218-1.00006-3_bib65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood-brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"Journal of Drug Targeting"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054182","article-title":"Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: A siRNA-chitosan approach","volume":"8","author":"Malmo","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-812218-1.00006-3_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.09.054","article-title":"Brain delivery of camptothecin by means of solid lipid nanoparticles: Formulation design, in vitro and in vivo studies","volume":"439","author":"Martins","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/B978-0-12-812218-1.00006-3_bib68","first-page":"632","article-title":"Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland","volume":"60","author":"Matschay","year":"2008","journal-title":"Pharmacological Reports"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm1055","article-title":"Signalling to and from tight junctions","volume":"4","author":"Matter","year":"2003","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib70","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/15672018113109990050","article-title":"Preparation and characterization of rivastigmine loaded human serum albumin (HSA) nanoparticles","volume":"11","author":"M. Avachat","year":"2014","journal-title":"Current Drug Delivery"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: Theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacological Reviews"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/03639045.2010.539231","article-title":"In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain","volume":"37","author":"Montenegro","year":"2011","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"15","key":"10.1016\/B978-0-12-812218-1.00006-3_bib73","first-page":"E599","article-title":"Heart disease and stroke statistics-2016 update: A report from the American Heart Association (vol 133, pg e38, 2016)","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrd3946","article-title":"2012 FDA drug approvals","volume":"12","author":"Mullard","year":"2013","journal-title":"Nature Reviews Drug Discovery"},{"issue":"149","key":"10.1016\/B978-0-12-812218-1.00006-3_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003594","article-title":"A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue","volume":"4","author":"Nance","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"12","key":"10.1016\/B978-0-12-812218-1.00006-3_bib76","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nature Medicine"},{"issue":"11","key":"10.1016\/B978-0-12-812218-1.00006-3_bib77","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2011.1282","article-title":"Depression and risk of stroke morbidity and mortality a meta-analysis and systematic review","volume":"306","author":"Pan","year":"2011","journal-title":"JAMA-Journal of the American Medical Association"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib78","first-page":"19","article-title":"A morphological approach to the analysis of blood-brain barrier transport function","volume":"45","author":"Pardridge","year":"1999","journal-title":"Brain Barrier Systems"},{"issue":"7","key":"10.1016\/B978-0-12-812218-1.00006-3_bib79","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/17425247.2013.784742","article-title":"Advances in brain drug targeting and delivery: Limitations and challenges of solid lipid nanoparticles","volume":"10","author":"Patel","year":"2013","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib80","article-title":"Getting into the brain approaches to enhance brain drug delivery","author":"Patel","year":"2009","journal-title":"Cns Drugs, 23(1), 35-58"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib81","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/1061186X.2010.523787","article-title":"Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route","volume":"19","author":"Patel","year":"2011","journal-title":"Journal of Drug Targeting"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood-brain barrier: Structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2015.10.059","article-title":"Bioactivity of noble metal nanoparticles decorated with biopolymers and their application in drug delivery","volume":"496","author":"Rai","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)06836-X","article-title":"Pharmacology of bradykinin and related kinins","volume":"32","author":"Regoli","year":"1980","journal-title":"Pharmacological Reviews"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","article-title":"Dynamics of brain-derived proteins in cerebrospinal fluid","volume":"310","author":"Reiber","year":"2001","journal-title":"Clinica Chimica Acta"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Reis","year":"2006","journal-title":"Nanomedicine-Nanotechnology Biology and Medicine"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib88","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/brain\/awg176","article-title":"Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis","volume":"126","author":"Schmidt","year":"2003","journal-title":"Brain"},{"issue":"4","key":"10.1016\/B978-0-12-812218-1.00006-3_bib89","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.bjp.0703379","article-title":"Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: Potential implications to L-DOPA long-term therapy of Parkinson\u2019s disease","volume":"130","author":"Serra","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejps.2014.09.021","article-title":"Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy","volume":"66","author":"Severino","year":"2015","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/B978-0-12-812218-1.00006-3_bib91","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ultrasmedbio.2004.04.010","article-title":"Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles","volume":"30","author":"Sheikov","year":"2004","journal-title":"Ultrasound in Medicine and Biology"},{"issue":"4","key":"10.1016\/B978-0-12-812218-1.00006-3_bib92","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1039\/C3NR04878K","article-title":"Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications","volume":"6","author":"Shilo","year":"2014","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib93","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.colsurfb.2008.07.004","article-title":"Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size","volume":"66","author":"Sonavane","year":"2008","journal-title":"Colloids and Surfaces B-Biointerfaces"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib94","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/nn4058215","article-title":"Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer\u2019s disease by accelerating the clearance of amyloid-beta","volume":"8","author":"Song","year":"2014","journal-title":"Acs Nano"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib95","doi-asserted-by":"crossref","DOI":"10.2174\/157341311794480264","article-title":"An overview on the design, development, characterization and applications of novel nanomedicines for brain targeting","volume":"7","author":"Souto","year":"2011","journal-title":"Current Nanoscience"},{"issue":"11","key":"10.1016\/B978-0-12-812218-1.00006-3_bib96","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","article-title":"Transporter-mediated permeation of drugs across the blood-brain barrier","volume":"89","author":"Tamai","year":"2000","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib97","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2015.01.019","article-title":"Exposure to 900MHz electromagnetic fields activates the mkp-1\/ERK pathway and causes blood-brain barrier damage and cognitive impairment in rats","volume":"1601","author":"Tang","year":"2015","journal-title":"Brain Research"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-812218-1.00006-3_bib98","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2007.03.007","article-title":"Glucocorticoids in the control of neuroinflammation","volume":"275","author":"Tischner","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"10.1016\/B978-0-12-812218-1.00006-3_bib99","doi-asserted-by":"crossref","first-page":"e0130442","DOI":"10.1371\/journal.pone.0130442","article-title":"Nano-drugs based on nano sterically stabilized liposomes for the treatment of inflammatory neurodegenerative diseases","volume":"10","author":"Turjeman","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the insulin receptor: Nanoparticles for drug delivery across the blood-brain barrier (BBB)","volume":"19","author":"Ulbrich","year":"2011","journal-title":"Journal of Drug Targeting"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib101","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nano.2012.03.003","article-title":"Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles","volume":"9","author":"Venishetty","year":"2013","journal-title":"Nanomedicine-Nanotechnology Biology and Medicine"},{"issue":"48","key":"10.1016\/B978-0-12-812218-1.00006-3_bib102","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1021\/bi0203987","article-title":"DNA nanoparticles and development of DNA delivery vehicles for gene therapy","volume":"41","author":"Vijayanathan","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib103","first-page":"S468","article-title":"Targeted liposomal drug delivery system for radionucleosides \u2013 a theranostic approach","volume":"43","author":"Vogg","year":"2016","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-812218-1.00006-3_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10735-006-9026-9","article-title":"Immunogold study of altered expression of some interendothelial junctional molecules in the brain blood microvessels of diabetic scrapie-infected mice","volume":"37","author":"Vorbrodt","year":"2006","journal-title":"Journal of Molecular Histology"},{"issue":"2","key":"10.1016\/B978-0-12-812218-1.00006-3_bib105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08982104.2014.954129","article-title":"Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery","volume":"25","author":"Wavikar","year":"2015","journal-title":"Journal of Liposome Research"},{"issue":"9","key":"10.1016\/B978-0-12-812218-1.00006-3_bib106","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/00207454.2013.877014","article-title":"Intracranial injection of PEG-PEI\/ROCK II-siRNA improves cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"124","author":"Wen","year":"2014","journal-title":"International Journal of Neuroscience"},{"issue":"21","key":"10.1016\/B978-0-12-812218-1.00006-3_bib107","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.1307152110","article-title":"Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor","volume":"110","author":"Wiley","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/B978-0-12-812218-1.00006-3_bib108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","article-title":"Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer\u2019s disease","volume":"1200","author":"Wilson","year":"2008","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib109","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood-brain barrier: Development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vascular Pharmacology"},{"issue":"1","key":"10.1016\/B978-0-12-812218-1.00006-3_bib110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00441-008-0658-9","article-title":"Brain endothelial cells and the glio-vascular complex","volume":"335","author":"Wolburg","year":"2009","journal-title":"Cell and Tissue Research"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib111","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/jcbfm.2014.220","article-title":"Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection","volume":"35","author":"Yemisci","year":"2015","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"3","key":"10.1016\/B978-0-12-812218-1.00006-3_bib112","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","article-title":"Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model","volume":"21","author":"Yusuf","year":"2013","journal-title":"Journal of Drug Targeting"},{"issue":"11","key":"10.1016\/B978-0-12-812218-1.00006-3_bib113","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1021\/am501341u","article-title":"Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-\u03b2 aggregation and cytotoxicity","volume":"6","author":"Zhang","year":"2014","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"6","key":"10.1016\/B978-0-12-812218-1.00006-3_bib114","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nature Reviews Neurology"}],"container-title":["Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128122181000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128122181000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:29:50Z","timestamp":1751599790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128122181000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128122181"],"references-count":114,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-812218-1.00006-3","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}